文献速递贫血与红细胞疾病

镰状细胞贫血患者白蛋白尿进展的多中心纵向研究

Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.
PubMed 文献 · Blood Adv · 2020-01-01

该前瞻性多中心纵向研究纳入303例镰状细胞贫血患者,每年采集稳态尿与血清,评估白蛋白/肌酐比值(ACR)、估算肾小球滤过率(eGFR)及生物标志物。结果显示白蛋白尿随年龄增长而进展,基线ACR≥100 mg/g可预测持续性白蛋白尿,后者与成人eGFR快速下降及慢性肾病(CKD)发生相关。

要点

  • 白蛋白尿在镰状细胞贫血患者中随年龄增长而进展,年均增加3.5 mg/g。
  • 基线ACR≥100 mg/g者81%发展为持续性白蛋白尿。
  • 持续性白蛋白尿与成人eGFR下降及CKD发生相关。

核心结论

  • 镰状细胞贫血患者白蛋白尿随年龄进展,成人白蛋白尿者eGFR下降更差。
  • 基线ACR≥100 mg/g可预测持续性白蛋白尿,后者与成人eGFR快速下降及CKD发生相关。

研究设计与样本

  • 前瞻性、多中心、纵向研究,纳入303例镰状细胞贫血参与者,每年采集稳态尿与血清样本。
  • 基线平均年龄21岁(范围2-64岁),32%存在白蛋白尿。
  • 持续性白蛋白尿定义为至少2次年度测量ACR≥30 mg/g。

主要发现

  • 纵向多变量分析中,ACR与性别、贫血、年龄较大、较高胆红素及肾损伤分子-1水平相关。
  • 白蛋白尿随年龄每年增加3.5 mg/g(P < .0001)。
  • 175例有至少3次年度样本的参与者中,基线白蛋白尿≥100 mg/g者81%发展为持续性白蛋白尿。
  • eGFR下降及成人CKD与持续性白蛋白尿相关(P = .002和P = .02),但与基线白蛋白尿无关。
  • 成人(而非儿童)中,白蛋白尿者eGFR下降速率较无白蛋白尿者更陡(P = .02);持续性白蛋白尿者较无者更易出现eGFR快速下降(P = .03)。

临床怎么用

  • 对镰状细胞贫血患者应纵向监测白蛋白尿,尤其基线ACR≥100 mg/g者,以识别持续性白蛋白尿及CKD高风险成人。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sickle cell nephropathy results in chronic kidney disease (CKD), which is associated with significant morbidity and mortality in sickle cell anemia (SCA). Albuminuria is an early manifestation of sickle nephropathy; however, little is known about progression of albuminuria or its correlation with glomerular filtration rate (GFR) decline or CKD. We studied nephropathy progression in 303 SCA participants in a prospective, multicenter, longitudinal study. We collected steady-state urine and serum samples yearly and assessed albumin/creatinine ratio (ACR), estimated GFR (eGFR), and SCA and nephropathy biomarkers. Participants with albuminuria (ACR ≥30 mg/g) for ≥2 annual measurements were classified as having persistent albuminuria (PA). At baseline (mean age, 21 years; range, 2-64 years), 32% had albuminuria. In longitudinal multivariate analysis, ACR was associated with sex, anemia, older age, and higher bilirubin and kidney injury molecule-1 levels. Albuminuria increased with age by 3.5 mg/g per year (P < .0001). Of 175 participants with ≥3 annual samples, 81% with baseline albuminuria ≥100 mg/g developed PA. Decreased eGFR and adult CKD were associated with PA (P = .002 and P = .02, respectively), but not with baseline albuminuria. Rate of eGFR decline was steeper among adults (but not children) with albuminuria, compared with those without (P = .02). Participants with PA were more likely to have rapid eGFR decline compared with those without (P = .03). In this longitudinal study, albuminuria progressed with age, and adults with albuminuria had worse eGFR decline than those without. Albuminuria ≥100 mg/g predicted PA, which was associated with rapid eGFR decline and CKD development in adults with SCA. This trial was registered at www.clinicaltrials.gov as #NCT02239016.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Niss O, Lane A, Asnani MR, et al. Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study. Blood Adv. 2020. PMID: 32289161. doi:10.1182/bloodadvances.2019001378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。